• ABOUT
  • TEAM
  • SERVICES
  • RESULTS
  • MEDIA & EVENTS

Theresa Covert Walker joins Plexus Ventures as Vice President

by plexusventures_h3tnl0 | Jun 11, 2021 | Uncategorized

Philadelphia, Pennsylvania – Plexus Ventures is pleased to announce the appointment of Theresa Covert Walker as Vice President based in the Pensacola area.  Theresa joins Plexus after a 27-year career at Merck & Co., bringing significant executive, business...

Pharma-DTx Partnerships: Webinar with Plexus Ventures and Healthware Labs

by plexusventures_h3tnl0 | May 19, 2021 | Uncategorized

Earlier this year, Healthware Group and Plexus Ventures formed an alliance to structure deals for the pharmaceutical industry in the development and commercialization of Digital Therapeutic (DTx) products. Given the increased attention...

Healthware Group and Plexus Ventures Form Alliance to Accelerate Partnerships Between Digital Therapeutics & Pharma

by plexusventures_h3tnl0 | Feb 16, 2021 | Uncategorized

Milan and New York, 16/2/2021 – Healthware Group and Plexus Ventures have formed an alliance to structure deals for the pharmaceutical industry in the development and commercialization of DTx products. Given the increased attention and growth seen in the market, both...

Plexus Ventures Assists Glenmark Pharmaceuticals to Out-License Ryaltris™ Nasal Spray to Menarini for numerous markets throughout Europe

by plexusventures_h3tnl0 | Jan 11, 2021 | Uncategorized

Philadelphia, Pennsylvania – Plexus Ventures is pleased to announce the successful conclusion of a licensing agreement of behalf of our client, Glenmark Pharmaceuticals. Mr. Michael O’Sullivan, Plexus Ventures’ Managing Partner, stated: “This transaction is an ideal...
« Older Entries
Next Entries »

Recent Posts

  • Plexus Ventures Assists First Pharma in Successful Completion of Business Sale to a Strategic Buyer
  • Plexus Ventures Assists Sanofi Consumer Health to Divest a Product Portfolio in Australia and South-East Asia to Phoenix Labs
  • Plexus Ventures Assists Elthera AG in the Licensing of its First-in-Class Antibody
  • Celon Pharma enters agreement with Zydus Lifesciences Ltd.
  • Mindpax engages Plexus Ventures as Exclusive Advisor to Partner its Digital Platform for Severe Mental Illnesses

Recent Comments

    Collaborating with clients to grow their businesses; committing our experience, resources and time to their success.

    Business Builders in Healthcare

    Contact Us
    • Follow

    About Us

    Our Team

    Areas of Expertise

    Project Portfolio

    What’s Trending